Section 522.2065 - Rabacfosadine(a)Specifications. Each vial of powder contains 16.4 milligrams (mg) rabacfosadine. Each milliliter of constituted solution contains 8.2 mg rabacfosadine.(b)Sponsor. See No. 058198 in § 510.600(c) of this chapter.(c)Conditions of use in dogs - (1)Amount. Administer rabacfosadine at 1 mg/kilogram body weight as a 30-minute intravenous infusion, once every 3 weeks, for up to 5 doses.(2)Indications for use. For the treatment of lymphoma in dogs.(3)Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian. 87 FR 10969 , Feb. 28, 2022